Tender detail
Open-house drug discount agreements for calcipotriol and betamethasone, excluding ointments and gels (ATC D05AX22)
Summary
The procurement covers non-exclusive discount agreements for medicines containing the active ingredients calcipotriol and betamethasone (ATC D05AX22); ointments and gels are excluded. Agreements may be concluded at any time under the open-house model from 1 January 2027 to 31 December 2028. Medicines included in the German BfArM list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.